Clinical Trials Browser

OTHER × Small Cell Lung Carcinoma × pembrolizumab × Clear all

NCT04358237 2025-06-04

LUPER

Phase 1/2 Completed

Recurrence, Small Cell Lung Carcinoma

NCT04187872 2023-12-27

TORCH

Phase 1 Terminated

CNSDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT02963090 2023-02-15

Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled 11 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT02934503 2021-11-16

Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)

Phase 2 Terminated

5 enrolled 5 charts

Small Cell Lung Carcinoma

NCT02551432 2020-02-10

MISP-MK3475

Phase 2 Completed

26 enrolled 9 charts

Small Cell Lung Carcinoma

NCT02331251 2018-07-02

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Phase 1/2 Terminated

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT02661100 2016-12-07

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Phase 1/2 Withdrawn

DermatologicOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Mesothelioma, Neoplasms, Small Cell Lung Carcinoma